Jun Liu
Directeur/Bestuurslid bij CHANGZHOU QIANHONG BIOPHARMA CO.,LTD
Vermogen: 19 M $ op 31-05-2024
Profiel
Jun Liu is currently a Director at Changzhou Qianhong Biopharma Co., Ltd., Zonhon Biopharma Institute, Inc., and Aucentra Therapeutics Pty Ltd.
He previously worked as a Director-Supervisory Board at Changzhou Bio-pharma Qianhong Co. Ltd.
and as a Member at Jiangsu Biological Technology Association.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-09-2022 | 18 044 733 ( 5.04% ) | 14 M $ | 31-05-2024 | |
| 30-09-2022 | 6 014 911 ( 0.65% ) | 5 M $ | 31-05-2024 |
Actieve functies van Jun Liu
| Bedrijven | Functie | Begin |
|---|---|---|
| CHANGZHOU QIANHONG BIOPHARMA CO.,LTD | Directeur/Bestuurslid | 15-05-2015 |
| Zonhon Biopharma Institute, Inc. | Directeur/Bestuurslid | 09-02-2015 |
Aucentra Therapeutics Pty Ltd.
 Aucentra Therapeutics Pty Ltd. BiotechnologyHealth Technology Aucentra Therapeutics Pty Ltd. is an Australian biotech company that develops advanced anti-cancer drugs. The private company is based in Adelaide, Australia. Established in 2017, the company focuses on breakthrough classes of drugs to address unmet medical needs for some of the most severe cancers, including leukaemia, breast cancer, colorectal cancer, glioblastoma, lung cancer, prostate cancer, and ovarian cancer. The company's pipeline consists of first-in-class or novel kinase inhibitors in pre-clinical and clinical stage development, with a particular focus on targeting cyclin dependent kinases (cdks), known for their over-expression in cancer cells. The company was founded in 2017 by Shudong Wang, and the CEO is Joe Bayer. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Jun Liu
| Bedrijven | Functie | Einde |
|---|---|---|
| Changzhou Bio-pharma Qianhong Co. Ltd. | Directeur/Bestuurslid | - |
| Jiangsu Biological Technology Association | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CHANGZHOU QIANHONG BIOPHARMA CO.,LTD | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
| Jiangsu Biological Technology Association | |
| Changzhou Bio-pharma Qianhong Co. Ltd. | |
| Zonhon Biopharma Institute, Inc. | |
Aucentra Therapeutics Pty Ltd.
Aucentra Therapeutics Pty Ltd. BiotechnologyHealth Technology Aucentra Therapeutics Pty Ltd. is an Australian biotech company that develops advanced anti-cancer drugs. The private company is based in Adelaide, Australia. Established in 2017, the company focuses on breakthrough classes of drugs to address unmet medical needs for some of the most severe cancers, including leukaemia, breast cancer, colorectal cancer, glioblastoma, lung cancer, prostate cancer, and ovarian cancer. The company's pipeline consists of first-in-class or novel kinase inhibitors in pre-clinical and clinical stage development, with a particular focus on targeting cyclin dependent kinases (cdks), known for their over-expression in cancer cells. The company was founded in 2017 by Shudong Wang, and the CEO is Joe Bayer. | Health Technology |
